|
1
|
Moore DD and Luu HH: Osteosarcoma. Cancer
Treat Res. 162:65–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Pediatric and adolescent osteosarcoma. Cancer
Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lamora A, Talbot J, Bougras G, Amiaud J,
Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann
MF, et al: Overexpression of smad7 blocks primary tumor growth and
lung metastasis development in osteosarcoma. Clin Cancer Res.
20:5097–5112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pece S, Serresi M, Santolini E, Capra M,
Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G and Di
Fiore PP: Loss of negative regulation by Numb over Notch is
relevant to human breast carcinogenesis. J Cell Biol. 167:215–221.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Zhang J, Ma D, Zhang L, Si M, Yin H
and Li J: Curcumin inhibits proliferation and invasion of
osteosarcoma cells through inactivation of Notch-1 signaling. FEBS
J. 279:2247–2259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diévart A, Beaulieu N and Jolicoeur P:
Involvement of Notch1 in the development of mouse mammary tumors.
Oncogene. 18:5973–5981. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garber K: Notch emerges as new cancer drug
target. J Natl Cancer Inst. 99:1284–1285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang SC, Lin XL, Wang HY, Qin YJ, Chen L,
Li J, Jia JS, Shen HF, Yang S, Xie RY, et al: Hes1 triggers
epithelial-mesenchymal transition (EMT)-like cellular marker
alterations and promotes invasion and metastasis of nasopharyngeal
carcinoma by activating the PTEN/AKT pathway. Oncotarget.
6:36713–36730. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Candy PA, Phillips MR, Redfern AD, Colley
SM, Davidson JA, Stuart LM, Wood BA, Zeps N and Leedman PJ:
Notch-Induced transcription factors are predictive of survival and
5-fluorouracil response in colorectal cancer patients. Br J Cancer.
109:1023–1030. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farnie G, Clarke RB, Spence K, Pinnock N,
Brennan K, Anderson NG and Bundred NJ: Novel cell culture technique
for primary ductal carcinoma in situ: Role of Notch and epidermal
growth factor receptor signaling pathways. J Natl Cancer Inst.
99:616–627. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Konishi J, Kawaguchi KS, Vo H, Haruki N,
Gonzalez A, Carbone DP and Dang TP: Gamma-secretase inhibitor
prevents Notch3 activation and reduces proliferation in human lung
cancers. Cancer Res. 67:8051–8057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bielack S, Carrle D and Casali PG; ESMO
Guidelines Working Group, : Osteosarcoma: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol.
20 (Suppl 4):S137–S139. 2009. View Article : Google Scholar
|
|
15
|
Ando K, Heymann MF, Stresing V, Mori K,
Rédini F and Heymann D: Current therapeutic strategies and novel
approaches in osteosarcoma. Cancers (Basel). 5:591–616. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao H, Yao Y, Wang Z, Lin F, Sun Y and
Chen P: Therapeutic effect of pirarubicin-based chemotherapy for
osteosarcoma patients with lung metastasis. J Chemother.
22:119–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He A, Yang X, Huang Y, Feng T, Wang Y, Sun
Y, Shen Z and Yao Y: CD133(+) CD44(+) cells mediate in the lung
metastasis of osteosarcoma. J Cell Biochem. 116:1719–1729. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Daw NC, Chou AJ, Jaffe N, Rao BN, Billups
CA, Rodriguez- Galindo C, Meyers PA and Huh WW: Recurrent
osteosarcoma with a single pulmonary metastasis: A
multi-institutional review. Br J Cancer. 112:278–282. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Faisham WI, Mat Saad AZ, Alsaigh LN, Nor
Azman MZ, Kamarul Imran M, Biswal BM, Bhavaraju VM, Salzihan MS,
Hasnan J, Ezane AM, et al: Prognostic factors and survival rate of
osteosarcoma: A single-institution study. Asia Pac J Clin Oncol.
13:e104–e110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen J, Ma L and Wei G: Comment on Fu et
al.: A systematic review of p53 as a biomarker of survival in
patients with osteosarcoma. Tumour Biol. 35:5049–5050. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shin SH, Jeong HJ, Han I, Cho HS and Kim
HS: Osteosarcoma and chondrosarcoma of the shoulder: Site-Specific
comparative analysis. Orthopedics. 36:e179–e185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miele L: Notch signaling. Clin Cancer Res.
12:1074–1079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chiba S: Notch signaling in stem cell
systems. Stem Cells. 24:2437–2447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Villanueva A, Alsinet C, Yanger K, Hoshida
Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S,
Stanger BZ and Llovet JM: Notch signaling is activated in human
hepatocellular carcinoma and induces tumor formation in mice.
Gastroenterology. 143:1660–1669.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bocchicchio S, Tesone M and Irusta G:
Convergence of wnt and notch signaling controls ovarian cancer cell
survival. J Cell Physiol. 234:22130–22143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lai XX, Li G, Lin B and Yang H:
Interference of Notch 1 inhibits the proliferation and invasion of
breast cancer cells: Involvement of the β-catenin signaling
pathway. Mol Med Rep. 17:2472–2478. 2018.PubMed/NCBI
|
|
29
|
Takebayashi K, Sasai Y, Sakai Y, Watanabe
T, Nakanishi S and Kageyama R: Structure, chromosomal locus, and
promoter analysis of the gene encoding the mouse helix-loop-helix
factor HES-1. Negative autoregulation through the multiple N box
elements. J Biol Chem. 269:5150–5156. 1994.PubMed/NCBI
|
|
30
|
Sasai Y, Kageyama R, Tagawa Y, Shigemoto R
and Nakanishi S: Two mammalian helix-loop-helix factors
structurally related to Drosophila hairy and enhancer of split.
Genes Dev. 6:2620–2634. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ishibashi M, Ang SL, Shiota K, Nakanishi
S, Kageyama R and Guillemot F: Targeted disruption of mammalian
hairy and Enhancer of split homolog-1 (HES-1) leads to
up-regulation of neural helix-loop-helix factors, premature
neurogenesis, and severe neural tube defects. Genes Dev.
9:3136–3148. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohtsuka T, Ishibashi M, Gradwohl G,
Nakanishi S, Guillemot F and Kageyama R: Hes1 and Hes5 as notch
effectors in mammalian neuronal differentiation. EMBO J.
18:2196–2207. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang P, Yang Y, Zweidler-McKay PA and
Hughes DP: Critical role of notch signaling in osteosarcoma
invasion and metastasis. Clin Cancer Res. 14:2962–2969. 2008.
View Article : Google Scholar : PubMed/NCBI
|
